Abbott Laboratories Articles
Abbott gets $100M under Simcor deal
24 March 2008
11 defendants settle US AWP litigation
24 March 2008
Takeda seeking to buy out TAP JV with Abbott?
24 March 2008
Abbott and Genentech sign Tarceva assay deal
17 March 2008
Humira and Naglazyme recommended for approval in Japan
10 March 2008
Japan stock market week to Mar 3, 2008
10 March 2008
Fournier challenges Teva's US generic TriCor
10 March 2008
Taiwan fake drugs seized in clinics
10 March 2008
FDA approves Abbott's Humira for JIA
3 March 2008
Abbott's Simcor gets FDA approval as cholesterol control treatment
25 February 2008
Kaletra impressive 48-week HIV reduction
25 February 2008
US DEA shift on e-Rx over paper records
18 February 2008
UK obesity drug Rxs pass million, increasing eightfold over 1999
14 February 2008
Amgen sells Takeda Japanese rights to 13 drugs in a deal that could be worth up to $1.2B
11 February 2008
IFPMA increases assistance to WHO-based TDR program
4 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
CHMP positive on low-dose Kaletra/Aluvia
4 February 2008
Fifth indication for Abbott's Humira
28 January 2008
Abbott Labs returns to profit in 4th-qtr 2007
28 January 2008
Thailand faces anti-pharma activists over Abbott drug
21 January 2008
Tokyo stocks to January 7, 2008
14 January 2008
New NDA submissions for Takeda and TAP
14 January 2008
Patent expiry for 2008 provides generic opportunity
14 January 2008
Humira cleared for plaque psoriasis in EU
7 January 2008
SkyePharma amends Flutiform deal with Abbott
7 January 2008
Tentative FDA appro for Noven's Stavzor
7 January 2008
OncoMethylome to test its biomarkers on Abbott's samples
24 December 2007
Axis-Shield on course for 9% revenue growth
24 December 2007
3rd-qtr global pharmaceutical R&D pipeline report from Fitch
17 December 2007
UPDATE: MedImmune's biologics capabilities to boost AstraZeneca's flagging pipeline
17 December 2007
PhRMA details Mexico flood relief by members
17 December 2007
B-MS to cut 10% of workforce in a bid to save $1.5B in time for loss of Plavix patent
17 December 2007
Japan stock market week to Dec 3, 2007
10 December 2007
UPDATE: Indonesia considers three more CLs
10 December 2007
Indonesia considers three more CLs
10 December 2007
Uganda among first countries to get pediatric Aluvia
10 December 2007
FDA panel backs Abbott's Xience stent
10 December 2007
CHMP issues negative view on Cimzia in Crohn's
26 November 2007
Strong animal data for Abbott's DVD-Igs
19 November 2007
"Devastating" AS ruling by the NICE condemned
19 November 2007
Chiesi and Abbott sign drug co-promotion deal
19 November 2007
Roche's Invirase non-inferior to Kaletra
5 November 2007
Abbott Labs' 3rd-qtr 2007 net earnings flat
29 October 2007
Solvay to co-promote Abbott's Simcor in USA
29 October 2007
Noven gets FDA "approvable letter" for Stavzor
29 October 2007
Japan stock market week to Oct 22, 2007
29 October 2007
GSK's Lexiva OK to use with 100mg ritonavir
22 October 2007
Aesica gets another manufacturing plant
22 October 2007
FDA moves to ensure thyroid drug potency
15 October 2007
Japan stock market week to October 1, 2007
8 October 2007
Prix Galien for Abbott's Humira
8 October 2007
Headlines 25 years ago this week....
1 October 2007
Micromet names Mark Reisenauer as senior VP and CCO
17 September 2007
ImClone to pay Repligen $65M in Erbitux case
17 September 2007
Dual Crestor/ABT-335 pill to enter Ph III
10 September 2007
NICE OK's Abbott Labs' Humira for PA
3 September 2007
Abbott COO to retire
13 August 2007
US state expands Rx drug database
13 August 2007
SkyePharma shares drop 16% as FDA questions Flutiform NDA; could delay appro to 2nd-qtr 2008
13 August 2007
UPDATE: Novartis loses India patent law challenge, no appeal planned, Glivec ruling awaited
13 August 2007
Abbott begins Ph I trial of ABT-560
6 August 2007
Abbott launches broad RealTime HIV-1 assay
30 July 2007
Peregrine in R&D deal with NIAID
23 July 2007
Abbott enrolls first patient in female Xience trial
23 July 2007
Abbott Labs' 2nd-qtr 2007 profit soars 61.4%
23 July 2007
Headlines 25 years ago this week....
23 July 2007
Abbott/GE terminate contract
16 July 2007
Thailand refuses Kaletra deal with Abbott
16 July 2007
Abbott Fund sponsors Tanzanian hospital lab
2 July 2007
Cethromycin "non-inferior" to Biaxin in CAP
2 July 2007
Abbott and Genentech collaborate on oncology
2 July 2007
Australian PBS reform will cost consumers
25 June 2007
Humira improves work performance in RA patients
25 June 2007
Lupin's generic Mavik gets FDA OK
18 June 2007
Humira gets EU OK for severe Crohn's
18 June 2007
Stock Commentary - New York week to May 28, 2007
4 June 2007
Thailand "may revoke" compulsory licence
28 May 2007
Peptech's six-month profits soar to $133M
28 May 2007
Abbott launches Crossroads Institute
28 May 2007
Japan stock market week to May 14, 2007
21 May 2007
MedImmune's 1st-qtr profit triples on Synagis
21 May 2007
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
